Hypertension and endothelial dysfunction in apolipoprotein-E deficient mice

被引：0
|
作者：
Yang, RH [1 ]
PowellBraxton, LM [1 ]
Ko, A [1 ]
Dybdal, N [1 ]
Bunting, S [1 ]
Jin, HK [1 ]
机构：
[1] GENENTECH INC,SAN FRANCISCO,CA 94080
来源：
CIRCULATION | 1997年 / 96卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3398 / 3398
页数：2
相关论文
共 50 条
  • [21] AORTIC VASCULAR-RESPONSE TO INJURY IN APOLIPOPROTEIN-E (APOE) DEFICIENT MICE
    REDDICK, RL
    ZHANG, S
    MAEDA, N
    FASEB JOURNAL, 1995, 9 (04): : A855 - A855
  • [22] Distribution and characteristics of peripheral atherosclerotic lesions in apolipoprotein-E deficient mice.
    Schwartz, SM
    Lombardi, DM
    Polinsky, PD
    Rosenfeld, ME
    Bunting, S
    PowellBraxton, L
    CIRCULATION, 1996, 94 (08) : 3700 - 3700
  • [23] Pioglitazone suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ
    Murakami-Nishida, Saiko
    Matsumura, Takeshi
    Senokuchi, Takafumi
    Ishii, Norio
    Kinoshita, Hiroyuki
    Yamada, Sarie
    Morita, Yutaro
    Nishida, Shuhei
    Motoshima, Hiroyuki
    Kondo, Tatsuya
    Komohara, Yoshihiro
    Araki, Eiichi
    ATHEROSCLEROSIS, 2019, 286 : 30 - 39
  • [24] Pioglitazone suppresses macrophage proliferation in apolipoprotein-E deficient mice by activating PPARγ
    Matsumura, T.
    Nishida, S. M.
    Nishida, S.
    Senokuchi, T.
    Ishii, N. Norio
    Morita, Y.
    Wada, T.
    Motoshima, H.
    Kondo, T.
    Araki, E.
    DIABETOLOGIA, 2019, 62 : S538 - S538
  • [25] The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice
    Libinaki, Roksan
    Vinh, Antony
    Tesanovic-Klajic, Sonja
    Widdop, Robert
    Gaspari, Tracey
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2017, 44 : 107 - 116
  • [26] Ghrelin-mediated pathway in Apolipoprotein-E deficient mice: a survival system
    Rezzani, Rita
    Franco, Caterina
    Favero, Gaia
    Rodella, Luigi F.
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2019, 11 (07): : 4263 - 4276
  • [27] Chronic treatment with the hexapeptide angiotensin IV improves endothelial dysfunction in apolipoprotein E-deficient mice
    Vinh, A
    Gaspari, TA
    Widdop, RE
    CIRCULATION, 2005, 112 (17) : U369 - U370
  • [28] Overexpression of interleukin-18 decreases plaque stability apolipoprotein-E deficient mice
    de Nooijer, R
    von der Thüsen, JH
    Kuiper, J
    Verkleij, CJ
    van Berkel, TJ
    Levy, S
    Biessen, EA
    CIRCULATION, 2003, 108 (17) : 224 - 224
  • [29] Deletion of cyclophilin d inhibits atherosclerotic plaque formation in apolipoprotein-e deficient mice
    Umezu, R.
    Koga, J.
    Tsutsui, H.
    Egashira, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 802 - 802
  • [30] Increased susceptibility to hepatic steatosis, inflammation and advanced fibrosis in apolipoprotein-E deficient mice
    Ferre, Natalia
    Martinez-Clemente, Marcos
    Lopez-Parra, Marta
    Gonzalez-Periz, Ana
    Horrillo, Raquel
    Planaguma, Anna
    Camps, Jordi
    Joven, Jorge
    Bataller, Ramon
    Arroyo, Vicente
    Rodes, Juan
    Claria, Joan
    HEPATOLOGY, 2007, 46 (04) : 707A - 708A
12345